Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Sotarauta

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
European Urology|January 1, 1988
Sequentially alternating hormone chemotherapy with high-dose medroxy-progesterone acetate and low-dose epirubicin for the treatment of hormone-resistant metastatic prostatic cancerM Kontturi, M Sotarauta, T Tammela, et al.
European Urology|January 1, 1990
Morphometry in human transitional cell bladder cancer. Nuclear area and standard deviation of nuclear area--relation to tumor grade (WHO) and prognosisP K Lipponen, Y Collan, M J Eskelinen, et al.
Scandinavian Journal of Urology and Nephrology|January 1, 1990
Volume corrected mitotic index (M/V index) in human bladder cancer; relation to histological grade (WHO), clinical stage (UICC) and prognosisP K Lipponen, Y Collan, M J Eskelinen, et al.
Pathology, Research and Practice|November 1, 1989
Potential of morphometry in grading transitional cell carcinoma of the urinary bladderP Lipponen, H Simpanen, E Pesonen, et al.
Annales Chirurgiae Et Gynaecologiae|January 1, 1987
A controlled, double-blind, cross-over study of terodiline in motor urge incontinenceO Lukkarinen, P Gröhn, G Wilén-Rosenqvist, et al.
British Journal of Urology|June 1, 1990
Comparison of morphometry and DNA flow cytometry with standard prognostic factors in bladder cancerP K Lipponen, Y Collan, M J Eskelinen, et al.
Urologia Internationalis|January 1, 1990
DNA ploidy and S phase fraction in human bladder cancer. Relation to survival and histological grade (WHO)P K Lipponen, M J Eskelinen, Y Collan, et al.
European Urology|January 1, 1991
Intravesical chemotherapy (mitomycin C) versus immunotherapy (bacillus Calmette-Guérin) in superficial bladder cancerE Rintala, K Jauhiainen, O Alfthan, et al.
Cancer|December 15, 1993
Multicenter randomized trial comparing Zoladex with Zoladex plus flutamide in the treatment of advanced prostate cancer. Survival update. International Prostate Cancer Study GroupC J Tyrrell, J E Altwein, F Klippel, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
European Urology|January 1, 1988
Sequentially alternating hormone chemotherapy with high-dose medroxy-progesterone acetate and low-dose epirubicin for the treatment of hormone-resistant metastatic prostatic cancerM Kontturi, M Sotarauta, T Tammela, et al.
European Urology|January 1, 1990
Morphometry in human transitional cell bladder cancer. Nuclear area and standard deviation of nuclear area--relation to tumor grade (WHO) and prognosisP K Lipponen, Y Collan, M J Eskelinen, et al.
Scandinavian Journal of Urology and Nephrology|January 1, 1990
Volume corrected mitotic index (M/V index) in human bladder cancer; relation to histological grade (WHO), clinical stage (UICC) and prognosisP K Lipponen, Y Collan, M J Eskelinen, et al.
Pathology, Research and Practice|November 1, 1989
Potential of morphometry in grading transitional cell carcinoma of the urinary bladderP Lipponen, H Simpanen, E Pesonen, et al.
Annales Chirurgiae Et Gynaecologiae|January 1, 1987
A controlled, double-blind, cross-over study of terodiline in motor urge incontinenceO Lukkarinen, P Gröhn, G Wilén-Rosenqvist, et al.
British Journal of Urology|June 1, 1990
Comparison of morphometry and DNA flow cytometry with standard prognostic factors in bladder cancerP K Lipponen, Y Collan, M J Eskelinen, et al.
Urologia Internationalis|January 1, 1990
DNA ploidy and S phase fraction in human bladder cancer. Relation to survival and histological grade (WHO)P K Lipponen, M J Eskelinen, Y Collan, et al.
European Urology|January 1, 1991
Intravesical chemotherapy (mitomycin C) versus immunotherapy (bacillus Calmette-Guérin) in superficial bladder cancerE Rintala, K Jauhiainen, O Alfthan, et al.
Cancer|December 15, 1993
Multicenter randomized trial comparing Zoladex with Zoladex plus flutamide in the treatment of advanced prostate cancer. Survival update. International Prostate Cancer Study GroupC J Tyrrell, J E Altwein, F Klippel, et al.
Pageof 2